|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
276 a.a.
|
 |
|
|
|
|
|
|
|
98 a.a.
|
 |
|
|
|
|
|
|
|
114 a.a.
|
 |
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Complex (mhc i/peptide/cd8)
|
 |
|
Title:
|
 |
Complex of the human mhc class i glycoprotein hla-a2 and the t cell coreceptor cd8
|
|
Structure:
|
 |
Mhc class i histocompatibility antigen (hla- a 0201) (Alpha chain). Chain: a. Fragment: extracellular domain. Synonym: hla-a2, hla-a 0201. Engineered: yes. Beta 2-microglobulin. Chain: b. Fragment: extracellular domain.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Cell_line: bl21. Gene: beta-2-microglobulin. Expressed in: escherichia coli. Expression_system_taxid: 562. Human immunodeficiency virus. Organism_taxid: 12721.
|
|
Biol. unit:
|
 |
Pentamer (from
)
|
|
Resolution:
|
 |
|
2.65Å
|
R-factor:
|
0.206
|
R-free:
|
0.276
|
|
|
Authors:
|
 |
J.Tormo,D.I.Stuart,E.Y.Jones
|
Key ref:
|
 |
G.F.Gao
et al.
(1997).
Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2.
Nature,
387,
630-634.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
21-May-97
|
Release date:
|
17-Sep-97
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
P01892
(1A02_HUMAN) -
HLA class I histocompatibility antigen, A-2 alpha chain
|
|
|
|
Seq: Struc:
|
 |
 |
 |
365 a.a.
276 a.a.
|
|
|
|
|
|
|
 |
 |
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
8 terms
|
 |
|
Biological process
|
immune response
|
8 terms
|
 |
|
Biochemical function
|
protein binding
|
1 term
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Nature
387:630-634
(1997)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2.
|
|
G.F.Gao,
J.Tormo,
U.C.Gerth,
J.R.Wyer,
A.J.McMichael,
D.I.Stuart,
J.I.Bell,
E.Y.Jones,
B.K.Jakobsen.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The dimeric cell-surface glycoprotein CD8 is crucial to the positive selection
of cytotoxic T cells in the thymus. The homodimer CD8alpha(alpha) or the
heterodimer alpha beta stabilizes the interaction of the T-cell antigen receptor
(TCR) with major histocompatibility complex (MHC) class I/peptide by binding to
the class I molecule. Here we report the crystal structure at 2.7 A resolution
of a complex between CD8alpha(alpha) and the human MHC molecule HLA-A2, which is
associated with peptide. CD8alpha(alpha) binds one HLA-A2/peptide molecule,
interfacing with the alpha2 and alpha3 domains of HLA-A2 and also contacting
beta2-microglobulin. A flexible loop of the alpha3 domain (residues 223-229) is
clamped between the complementarity-determining region (CDR)-like loops of the
two CD8 subunits in the classic manner of an antibody-antigen interaction,
precluding the binding of a second MHC molecule. The position of the alpha3
domain is different from that in uncomplexed HLA-A2, being most similar to that
in the TCR/Tax/HLA-A2 complex, but no conformational change extends to the
MHC/peptide surface presented for TCR recognition. Although these shifts in
alpha3 may provide a synergistic modulation of affinity, the binding of CD8 to
MHC is clearly consistent with an avidity-based contribution from CD8 to
TCR-peptide-MHC interactions.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1 The structure of the CD8  /HLA-A2/peptide
complex and the interaction surfaces. a, Stereo view of the
complex. The HLA-A2 heavy chain (green), [2]m
(gold), CD8 -1
(red) and CD8 -2
(blue) are depicted schematically, and the pol peptide
(ILKEPVHGV) is shown in white as a ball-and-stick
representation. Secondary structure assignments are from program
DSSP24, modified in places to accord with previous reports. This
orientation defines a standard view for b-d. b, The interaction
surfaces. The solvent-accessible surface of CD8  (calculated
in the absence of the rest of the complex by the program
VOLUMES; R. Esnouf, unpublished) is shown as a semi-transparent
surface. The regions depicted in close up in c and d are
indicated by a circle and a rectangle, respectively. The
polypeptide chains are represented schematically as in a but the
view is slightly rotated about the horizontal. c, The HLA-A2
3/CD8
 interaction
surface. d, The HLA-A2 2,
[2]m
and CD8 -1
interaction surface. Components of this figure and of Fig. 2
were drawn using programs MOLSCRIPT25 (with modifications by R.
Esnouf) and RASTER3D^26;
|
 |
Figure 2.
Figure 2 Structural comparisons and models. a, Range of
positional variation for the MHC class I 3
domain. Equivalent C atoms
for the MHC heavy-chain residues 1-174 were used to generate
pairwise superpositions taking residues from the HLA-B53/ls6
complex as the common reference set27. C traces
for the heavy chains and [2]m
from isolated MHC class I/peptide complexes (PDB codes: 1hhg,
1hhh, 1hhi, 1hhj, 1hhk, 1hsb, 1mhc, 1vac, 1vad, 2clr, 2vag, 2vab
and 3hla) are shown in yellow; the HLA-A2 heavy chain and [2]m
from the HLA-A2/TCR complex5 are coloured red, and those from
the CD8  /HLA-A2/peptide
complex are coloured blue. The peptide of the CD8  /HLA-A2/peptide
complex is shown in white. b, Loss of the CD8 binding
conformation for the 223-229 loop in HLA-Aw68. Equivalent C atoms
were used to generate superpositions for the 3
domains of uncomplexed HLA-A2 (yellow), HLA-Aw68 (green) and
HLA-A2 when complexed with CD8  (blue).
For clarity, the right-hand-side close up is rotated about the
vertical relative to the standard view. The hydrogen bond
defining the turn
between residues 224-227 is shown as a broken line and is
conserved in both the isolated and complexed HLA-A2 structures
but is lost for the distorted loop conformation of HLA-Aw68.
This turn
is central to the interaction of 3
and CD8 (Fig. 1c). c, A model for CD8 and TCR binding to MHC
class I. The putative position of the TCR relative to the CD8
 /HLA-A2/peptide
complex is based on a superposition of the TCR/Tax/HLA-A2
complex5 generated using equivalent C atoms
for HLA-A2 residues 1-174. The HLA-A2 heavy chain (green), [2]m
(gold), CD8 -1
(red) and CD8 -2
(blue) are depicted schematically, and the pol peptide is shown
in white as a ball-and-stick representation. The superposed TCR
(variable
domain) and (variable
and constant domains) are shown in light and dark pink,
respectively. The approximate positions of the T-cell and
antigen-presenting cell surfaces are indicated by broad broken
lines. Structural superpositions were performed using the
program SHP28.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Macmillan Publishers Ltd:
Nature
(1997,
387,
630-634)
copyright 1997.
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.Zloza,
M.C.Jagoda,
G.E.Lyons,
M.C.Graves,
F.J.Kohlhapp,
J.A.O'Sullivan,
A.T.Lacek,
M.I.Nishimura,
and
J.A.Guevara-Patiño
(2011).
CD8 Co-receptor promotes susceptibility of CD8(+) T cells to transforming growth factor-β (TGF-β)-mediated suppression.
|
| |
Cancer Immunol Immunother, 60,
291-297.
|
 |
|
|
|
|
 |
N.Jiang,
J.Huang,
L.J.Edwards,
B.Liu,
Y.Zhang,
C.D.Beal,
B.D.Evavold,
and
C.Zhu
(2011).
Two-stage cooperative T cell receptor-peptide major histocompatibility complex-CD8 trimolecular interactions amplify antigen discrimination.
|
| |
Immunity, 34,
13-23.
|
 |
|
|
|
|
 |
A.O.Tarakanov,
and
K.G.Fuxe
(2010).
Triplet puzzle: homologies of receptor heteromers.
|
| |
J Mol Neurosci, 41,
294-303.
|
 |
|
|
|
|
 |
L.Li,
J.M.Herndon,
S.M.Truscott,
T.H.Hansen,
T.P.Fleming,
P.Goedegebuure,
and
W.E.Gillanders
(2010).
Engineering superior DNA vaccines: MHC class I single chain trimers bypass antigen processing and enhance the immune response to low affinity antigens.
|
| |
Vaccine, 28,
1911-1918.
|
 |
|
|
|
|
 |
L.Wooldridge,
B.Laugel,
J.Ekeruche,
M.Clement,
H.A.van den Berg,
D.A.Price,
and
A.K.Sewell
(2010).
CD8 controls T cell cross-reactivity.
|
| |
J Immunol, 185,
4625-4632.
|
 |
|
|
|
|
 |
L.Wooldridge,
M.Clement,
A.Lissina,
E.S.Edwards,
K.Ladell,
J.Ekeruche,
R.E.Hewitt,
B.Laugel,
E.Gostick,
D.K.Cole,
R.Debets,
C.Berrevoets,
J.J.Miles,
S.R.Burrows,
D.A.Price,
and
A.K.Sewell
(2010).
MHC class I molecules with Superenhanced CD8 binding properties bypass the requirement for cognate TCR recognition and nonspecifically activate CTLs.
|
| |
J Immunol, 184,
3357-3366.
|
 |
|
|
|
|
 |
M.S.Bennett,
A.Joseph,
H.L.Ng,
H.Goldstein,
and
O.O.Yang
(2010).
Fine-tuning of T-cell receptor avidity to increase HIV epitope variant recognition by cytotoxic T lymphocytes.
|
| |
AIDS, 24,
2619-2628.
|
 |
|
|
|
|
 |
Y.J.Kang,
X.Wang,
S.J.Lin,
Y.M.Hsu,
and
H.C.Chang
(2010).
An active CD8alpha/pMHCI interaction is required for CD8 single positive thymocyte differentiation.
|
| |
Eur J Immunol, 40,
836-848.
|
 |
|
|
|
|
 |
A.Goyos,
Y.Ohta,
S.Guselnikov,
and
J.Robert
(2009).
Novel nonclassical MHC class Ib genes associated with CD8 T cell development and thymic tumors.
|
| |
Mol Immunol, 46,
1775-1786.
|
 |
|
|
|
|
 |
A.S.Chervin,
J.D.Stone,
P.D.Holler,
A.Bai,
J.Chen,
H.N.Eisen,
and
D.M.Kranz
(2009).
The impact of TCR-binding properties and antigen presentation format on T cell responsiveness.
|
| |
J Immunol, 183,
1166-1178.
|
 |
|
|
|
|
 |
J.D.Taurog,
M.L.Dorris,
N.Satumtira,
T.M.Tran,
R.Sharma,
R.Dressel,
J.van den Brandt,
and
H.M.Reichardt
(2009).
Spondylarthritis in HLA-B27/human beta(2)-microglobulin-transgenic rats is not prevented by lack of CD8.
|
| |
Arthritis Rheum, 60,
1977-1984.
|
 |
|
|
|
|
 |
L.Wooldridge,
A.Lissina,
D.K.Cole,
H.A.van den Berg,
D.A.Price,
and
A.K.Sewell
(2009).
Tricks with tetramers: how to get the most from multimeric peptide-MHC.
|
| |
Immunology, 126,
147-164.
|
 |
|
|
|
|
 |
L.Zong,
Y.Chen,
H.Peng,
F.Gao,
A.Iwamoto,
and
G.F.Gao
(2009).
Rhesus macaque: a tight homodimeric CD8alphaalpha.
|
| |
Proteins, 75,
241-244.
|
 |
|
|
|
|
 |
R.Wang,
K.Natarajan,
and
D.H.Margulies
(2009).
Structural basis of the CD8 alpha beta/MHC class I interaction: focused recognition orients CD8 beta to a T cell proximal position.
|
| |
J Immunol, 183,
2554-2564.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.Chen,
Y.Shi,
H.Cheng,
Y.Q.An,
and
G.F.Gao
(2009).
Structural immunology and crystallography help immunologists see the immune system in action: how T and NK cells touch their ligands.
|
| |
IUBMB Life, 61,
579-590.
|
 |
|
|
|
|
 |
C.C.Bell,
V.Han,
and
N.B.Sawtell
(2008).
Cerebellum-like structures and their implications for cerebellar function.
|
| |
Annu Rev Neurosci, 31,
1.
|
 |
|
|
|
|
 |
D.A.Shore,
H.Issafras,
E.Landais,
L.Teyton,
and
I.A.Wilson
(2008).
The crystal structure of CD8 in complex with YTS156.7.7 Fab and interaction with other CD8 antibodies define the binding mode of CD8 alphabeta to MHC class I.
|
| |
J Mol Biol, 384,
1190-1202.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.Cihakova,
J.G.Barin,
G.C.Baldeviano,
M.Kimura,
M.V.Talor,
D.H.Zimmerman,
E.Talor,
and
N.R.Rose
(2008).
L.E.A.P.S. heteroconjugate is able to prevent and treat experimental autoimmune myocarditis by altering trafficking of autoaggressive cells to the heart.
|
| |
Int Immunopharmacol, 8,
624-633.
|
 |
|
|
|
|
 |
E.J.Collins,
and
D.S.Riddle
(2008).
TCR-MHC docking orientation: natural selection, or thymic selection?
|
| |
Immunol Res, 41,
267-294.
|
 |
|
|
|
|
 |
H.Cheroutre,
and
F.Lambolez
(2008).
Doubting the TCR coreceptor function of CD8alphaalpha.
|
| |
Immunity, 28,
149-159.
|
 |
|
|
|
|
 |
J.D.Silk,
M.Salio,
J.Brown,
E.Y.Jones,
and
V.Cerundolo
(2008).
Structural and functional aspects of lipid binding by CD1 molecules.
|
| |
Annu Rev Cell Dev Biol, 24,
369-395.
|
 |
|
|
|
|
 |
J.J.Melenhorst,
P.Scheinberg,
P.K.Chattopadhyay,
A.Lissina,
E.Gostick,
D.K.Cole,
L.Wooldridge,
H.A.van den Berg,
E.Bornstein,
N.F.Hensel,
D.C.Douek,
M.Roederer,
A.K.Sewell,
A.J.Barrett,
and
D.A.Price
(2008).
Detection of low avidity CD8(+) T cell populations with coreceptor-enhanced peptide-major histocompatibility complex class I tetramers.
|
| |
J Immunol Methods, 338,
31-39.
|
 |
|
|
|
|
 |
N.Caporale,
and
Y.Dan
(2008).
Spike timing-dependent plasticity: a Hebbian learning rule.
|
| |
Annu Rev Neurosci, 31,
25-46.
|
 |
|
|
|
|
 |
N.R.Gascoigne
(2008).
Do T cells need endogenous peptides for activation?
|
| |
Nat Rev Immunol, 8,
895-900.
|
 |
|
|
|
|
 |
O.Dushek,
and
D.Coombs
(2008).
Analysis of serial engagement and peptide-MHC transport in T cell receptor microclusters.
|
| |
Biophys J, 94,
3447-3460.
|
 |
|
|
|
|
 |
P.K.Chattopadhyay,
J.J.Melenhorst,
K.Ladell,
E.Gostick,
P.Scheinberg,
A.J.Barrett,
L.Wooldridge,
M.Roederer,
A.K.Sewell,
and
D.A.Price
(2008).
Techniques to improve the direct ex vivo detection of low frequency antigen-specific CD8+ T cells with peptide-major histocompatibility complex class I tetramers.
|
| |
Cytometry A, 73,
1001-1009.
|
 |
|
|
|
|
 |
S.Endo,
Y.Sakamoto,
E.Kobayashi,
A.Nakamura,
and
T.Takai
(2008).
Regulation of cytotoxic T lymphocyte triggering by PIR-B on dendritic cells.
|
| |
Proc Natl Acad Sci U S A, 105,
14515-14520.
|
 |
|
|
|
|
 |
W.Held,
and
R.A.Mariuzza
(2008).
Cis interactions of immunoreceptors with MHC and non-MHC ligands.
|
| |
Nat Rev Immunol, 8,
269-278.
|
 |
|
|
|
|
 |
Z.Yang,
and
P.J.Bjorkman
(2008).
Structure of UL18, a peptide-binding viral MHC mimic, bound to a host inhibitory receptor.
|
| |
Proc Natl Acad Sci U S A, 105,
10095-10100.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Thedrez,
C.de Lalla,
S.Allain,
L.Zaccagnino,
S.Sidobre,
C.Garavaglia,
G.Borsellino,
P.Dellabona,
M.Bonneville,
E.Scotet,
and
G.Casorati
(2007).
CD4 engagement by CD1d potentiates activation of CD4+ invariant NKT cells.
|
| |
Blood, 110,
251-258.
|
 |
|
|
|
|
 |
B.Laugel,
H.A.van den Berg,
E.Gostick,
D.K.Cole,
L.Wooldridge,
J.Boulter,
A.Milicic,
D.A.Price,
and
A.K.Sewell
(2007).
Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties.
|
| |
J Biol Chem, 282,
23799-23810.
|
 |
|
|
|
|
 |
D.Hatherley,
K.Harlos,
D.C.Dunlop,
D.I.Stuart,
and
A.N.Barclay
(2007).
The structure of the macrophage signal regulatory protein alpha (SIRPalpha) inhibitory receptor reveals a binding face reminiscent of that used by T cell receptors.
|
| |
J Biol Chem, 282,
14567-14575.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.K.Cole,
P.J.Rizkallah,
J.M.Boulter,
M.Sami,
A.L.Vuidepot,
M.Glick,
F.Gao,
J.I.Bell,
B.K.Jakobsen,
and
G.F.Gao
(2007).
Computational design and crystal structure of an enhanced affinity mutant human CD8 alphaalpha coreceptor.
|
| |
Proteins, 67,
65-74.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.Garino,
J.Miertus,
M.Berrino,
F.Bertinetto,
P.Caropreso,
V.Gay,
G.Mazzola,
F.Tondat,
V.Frecer,
S.Miertus,
and
A.Amoroso
(2007).
Molecular aspects of a novel HLA-A*02 allele (A*0297): the first HLA class I allele mutated at codon 232.
|
| |
Tissue Antigens, 69,
342-347.
|
 |
|
|
|
|
 |
E.Gostick,
D.K.Cole,
S.L.Hutchinson,
L.Wooldridge,
S.Tafuro,
B.Laugel,
A.Lissina,
A.Oxenius,
J.M.Boulter,
D.A.Price,
and
A.K.Sewell
(2007).
Functional and biophysical characterization of an HLA-A*6801-restricted HIV-specific T cell receptor.
|
| |
Eur J Immunol, 37,
479-486.
|
 |
|
|
|
|
 |
F.Yuan,
T.Georgiou,
T.Hillon,
E.Gostick,
D.A.Price,
A.K.Sewell,
R.Moysey,
J.Gavarret,
A.Vuidepot,
M.Sami,
J.I.Bell,
G.F.Gao,
P.J.Rizkallah,
and
B.K.Jakobsen
(2007).
Crystallization and preliminary X-ray structural studies of a Melan-A pMHC-TCR complex.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun, 63,
758-760.
|
 |
|
|
|
|
 |
J.Chen,
M.Chloupková,
J.Gao,
T.L.Chapman-Arvedson,
and
C.A.Enns
(2007).
HFE Modulates Transferrin Receptor 2 Levels in Hepatoma Cells via Interactions That Differ from Transferrin Receptor 1-HFE Interactions.
|
| |
J Biol Chem, 282,
36862-36870.
|
 |
|
|
|
|
 |
L.Wooldridge,
A.Lissina,
J.Vernazza,
E.Gostick,
B.Laugel,
S.L.Hutchinson,
F.Mirza,
P.R.Dunbar,
J.M.Boulter,
M.Glick,
V.Cerundolo,
H.A.van den Berg,
D.A.Price,
and
A.K.Sewell
(2007).
Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region.
|
| |
Eur J Immunol, 37,
1323-1333.
|
 |
|
|
|
|
 |
M.Koch,
S.Camp,
T.Collen,
D.Avila,
J.Salomonsen,
H.J.Wallny,
A.van Hateren,
L.Hunt,
J.P.Jacob,
F.Johnston,
D.A.Marston,
I.Shaw,
P.R.Dunbar,
V.Cerundolo,
E.Y.Jones,
and
J.Kaufman
(2007).
Structures of an MHC class I molecule from B21 chickens illustrate promiscuous peptide binding.
|
| |
Immunity, 27,
885-899.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.S.Kuhns,
and
M.M.Davis
(2007).
Disruption of extracellular interactions impairs T cell receptor-CD3 complex stability and signaling.
|
| |
Immunity, 26,
357-369.
|
 |
|
|
|
|
 |
P.Zhou,
F.Tian,
and
Z.Li
(2007).
A structure-based, quantitative structure-activity relationship approach for predicting HLA-A*0201-restricted cytotoxic T lymphocyte epitopes.
|
| |
Chem Biol Drug Des, 69,
56-67.
|
 |
|
|
|
|
 |
S.X.Wang,
K.C.Pandey,
J.Scharfstein,
J.Whisstock,
R.K.Huang,
J.Jacobelli,
R.J.Fletterick,
P.J.Rosenthal,
M.Abrahamson,
L.S.Brinen,
A.Rossi,
A.Sali,
and
J.H.McKerrow
(2007).
The structure of chagasin in complex with a cysteine protease clarifies the binding mode and evolution of an inhibitor family.
|
| |
Structure, 15,
535-543.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Thilo,
P.Berglund,
S.E.Applequist,
J.W.Yewdell,
H.G.Ljunggren,
and
A.Achour
(2006).
Dissection of the interaction of the human cytomegalovirus-derived US2 protein with major histocompatibility complex class I molecules: prominent role of a single arginine residue in human leukocyte antigen-A2.
|
| |
J Biol Chem, 281,
8950-8957.
|
 |
|
|
|
|
 |
D.H.Bos,
and
B.Waldman
(2006).
Polymorphism, natural selection, and structural modeling of class Ia MHC in the African clawed frog (Xenopus laevis).
|
| |
Immunogenetics, 58,
433-442.
|
 |
|
|
|
|
 |
H.C.Chang,
K.Tan,
and
Y.M.Hsu
(2006).
CD8alphabeta has two distinct binding modes of interaction with peptide-major histocompatibility complex class I.
|
| |
J Biol Chem, 281,
28090-28096.
|
 |
|
|
|
|
 |
K.Natarajan,
A.Hicks,
J.Mans,
H.Robinson,
R.Guan,
R.A.Mariuzza,
and
D.H.Margulies
(2006).
Crystal structure of the murine cytomegalovirus MHC-I homolog m144.
|
| |
J Mol Biol, 358,
157-171.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.Wooldridge,
T.J.Scriba,
A.Milicic,
B.Laugel,
E.Gostick,
D.A.Price,
R.E.Phillips,
and
A.K.Sewell
(2006).
Anti-coreceptor antibodies profoundly affect staining with peptide-MHC class I and class II tetramers.
|
| |
Eur J Immunol, 36,
1847-1855.
|
 |
|
|
|
|
 |
M.G.Rudolph,
R.L.Stanfield,
and
I.A.Wilson
(2006).
How TCRs bind MHCs, peptides, and coreceptors.
|
| |
Annu Rev Immunol, 24,
419-466.
|
 |
|
|
|
|
 |
M.Shiroishi,
K.Kuroki,
T.Ose,
L.Rasubala,
I.Shiratori,
H.Arase,
K.Tsumoto,
I.Kumagai,
D.Kohda,
and
K.Maenaka
(2006).
Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer.
|
| |
J Biol Chem, 281,
10439-10447.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.P.Yachi,
J.Ampudia,
T.Zal,
and
N.R.Gascoigne
(2006).
Altered peptide ligands induce delayed CD8-T cell receptor interaction--a role for CD8 in distinguishing antigen quality.
|
| |
Immunity, 25,
203-211.
|
 |
|
|
|
|
 |
A.Poggi,
P.Contini,
S.Catellani,
M.Setti,
G.Murdaca,
and
M.R.Zocchi
(2005).
Regulation of gammadelta T cell survival by soluble HLA-I: involvement of CD8 and activating killer Ig-like receptors.
|
| |
Eur J Immunol, 35,
2670-2678.
|
 |
|
|
|
|
 |
C.C.Chang,
M.Campoli,
N.P.Restifo,
X.Wang,
and
S.Ferrone
(2005).
Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy.
|
| |
J Immunol, 174,
1462-1471.
|
 |
|
|
|
|
 |
D.K.Cole,
P.J.Rizkallah,
M.Sami,
N.M.Lissin,
F.Gao,
J.I.Bell,
J.M.Boulter,
M.Glick,
A.L.Vuidepot,
B.K.Jakobsen,
and
G.F.Gao
(2005).
Crystallization and preliminary X-ray structural studies of a high-affinity CD8alphaalpha co-receptor to pMHC.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun, 61,
285-287.
|
 |
|
|
|
|
 |
D.M.Gakamsky,
I.F.Luescher,
A.Pramanik,
R.B.Kopito,
F.Lemonnier,
H.Vogel,
R.Rigler,
and
I.Pecht
(2005).
CD8 kinetically promotes ligand binding to the T-cell antigen receptor.
|
| |
Biophys J, 89,
2121-2133.
|
 |
|
|
|
|
 |
H.C.Chang,
K.Tan,
J.Ouyang,
E.Parisini,
J.H.Liu,
Y.Le,
X.Wang,
E.L.Reinherz,
and
J.H.Wang
(2005).
Structural and mutational analyses of a CD8alphabeta heterodimer and comparison with the CD8alphaalpha homodimer.
|
| |
Immunity, 23,
661-671.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.Wooldridge,
H.A.van den Berg,
M.Glick,
E.Gostick,
B.Laugel,
S.L.Hutchinson,
A.Milicic,
J.M.Brenchley,
D.C.Douek,
D.A.Price,
and
A.K.Sewell
(2005).
Interaction between the CD8 coreceptor and major histocompatibility complex class I stabilizes T cell receptor-antigen complexes at the cell surface.
|
| |
J Biol Chem, 280,
27491-27501.
|
 |
|
|
|
|
 |
M.Sachdev,
R.Sankaranarayanan,
P.Reddanna,
K.Thangaraj,
and
L.Singh
(2005).
Major histocompatibility complex class I polymorphism in Asiatic lions.
|
| |
Tissue Antigens, 66,
9.
|
 |
|
|
|
|
 |
M.Valés-Gómez,
M.Shiroishi,
K.Maenaka,
and
H.T.Reyburn
(2005).
Genetic variability of the major histocompatibility complex class I homologue encoded by human cytomegalovirus leads to differential binding to the inhibitory receptor ILT2.
|
| |
J Virol, 79,
2251-2260.
|
 |
|
|
|
|
 |
N.Dimasi,
and
R.Biassoni
(2005).
Structural and functional aspects of the Ly49 natural killer cell receptors.
|
| |
Immunol Cell Biol, 83,
1-8.
|
 |
|
|
|
|
 |
O.J.Kwon,
S.H.Hwang,
S.S.Hur,
and
H.B.Oh
(2005).
Novel HLA-Cw*01 allele, Cw*0111, identified by sequence-based typing.
|
| |
Tissue Antigens, 66,
706-707.
|
 |
|
|
|
|
 |
O.Y.Borbulevych,
T.K.Baxter,
Z.Yu,
N.P.Restifo,
and
B.M.Baker
(2005).
Increased immunogenicity of an anchor-modified tumor-associated antigen is due to the enhanced stability of the peptide/MHC complex: implications for vaccine design.
|
| |
J Immunol, 174,
4812-4820.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.P.Cardenas,
C.F.Suarez,
P.Martinez,
M.E.Patarroyo,
and
M.A.Patarroyo
(2005).
MHC class I genes in the owl monkey: mosaic organisation, convergence and loci diversity.
|
| |
Immunogenetics, 56,
818-832.
|
 |
|
|
|
|
 |
T.Raine,
and
R.Allen
(2005).
MHC-I recognition by receptors on myelomonocytic cells: new tricks for old dogs?
|
| |
Bioessays, 27,
542-550.
|
 |
|
|
|
|
 |
C.A.Wright,
P.Kozik,
M.Zacharias,
and
S.Springer
(2004).
Tapasin and other chaperones: models of the MHC class I loading complex.
|
| |
Biol Chem, 385,
763-778.
|
 |
|
|
|
|
 |
K.L.Arnett,
S.C.Harrison,
and
D.C.Wiley
(2004).
Crystal structure of a human CD3-epsilon/delta dimer in complex with a UCHT1 single-chain antibody fragment.
|
| |
Proc Natl Acad Sci U S A, 101,
16268-16273.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Giroux,
and
F.Denis
(2004).
Influence of calcium ions in the flow cytometric analysis of human CD8-positive cells.
|
| |
Cytometry A, 62,
61-64.
|
 |
|
|
|
|
 |
N.R.Gascoigne,
and
T.Zal
(2004).
Molecular interactions at the T cell-antigen-presenting cell interface.
|
| |
Curr Opin Immunol, 16,
114-119.
|
 |
|
|
|
|
 |
T.K.Baxter,
S.J.Gagnon,
R.L.Davis-Harrison,
J.C.Beck,
A.K.Binz,
R.V.Turner,
W.E.Biddison,
and
B.M.Baker
(2004).
Strategic mutations in the class I major histocompatibility complex HLA-A2 independently affect both peptide binding and T cell receptor recognition.
|
| |
J Biol Chem, 279,
29175-29184.
|
 |
|
|
|
|
 |
A.H.Merry,
R.J.Gilbert,
D.A.Shore,
L.Royle,
O.Miroshnychenko,
M.Vuong,
M.R.Wormald,
D.J.Harvey,
R.A.Dwek,
B.J.Classon,
P.M.Rudd,
and
S.J.Davis
(2003).
O-glycan sialylation and the structure of the stalk-like region of the T cell co-receptor CD8.
|
| |
J Biol Chem, 278,
27119-27128.
|
 |
|
|
|
|
 |
A.J.Bankovich,
and
K.C.Garcia
(2003).
Not just any T cell receptor will do.
|
| |
Immunity, 18,
7.
|
 |
|
|
|
|
 |
A.M.Moody,
S.J.North,
B.Reinhold,
S.J.Van Dyken,
M.E.Rogers,
M.Panico,
A.Dell,
H.R.Morris,
J.D.Marth,
and
E.L.Reinherz
(2003).
Sialic acid capping of CD8beta core 1-O-glycans controls thymocyte-major histocompatibility complex class I interaction.
|
| |
J Biol Chem, 278,
7240-7246.
|
 |
|
|
|
|
 |
A.N.Barclay
(2003).
Membrane proteins with immunoglobulin-like domains--a master superfamily of interaction molecules.
|
| |
Semin Immunol, 15,
215-223.
|
 |
|
|
|
|
 |
A.Scardino,
P.Correale,
H.Firat,
M.Pellegrini,
K.Kosmatopoulos,
P.Opolon,
P.Alves,
R.Zurbriggen,
R.Glück,
F.A.Lemonnier,
G.Francini,
and
M.G.Cusi
(2003).
In vivo study of the GC90/IRIV vaccine for immune response and autoimmunity into a novel humanised transgenic mouse.
|
| |
Br J Cancer, 89,
199-205.
|
 |
|
|
|
|
 |
A.Williams,
P.D.Roberts,
and
T.K.Leen
(2003).
Stability of negative-image equilibria in spike-timing-dependent plasticity.
|
| |
Phys Rev E Stat Nonlin Soft Matter Phys, 68,
021923.
|
 |
|
|
|
|
 |
J.Buslepp,
H.Wang,
W.E.Biddison,
E.Appella,
and
E.J.Collins
(2003).
A correlation between TCR Valpha docking on MHC and CD8 dependence: implications for T cell selection.
|
| |
Immunity, 19,
595-606.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.H.Wang,
and
M.J.Eck
(2003).
Assembling atomic resolution views of the immunological synapse.
|
| |
Curr Opin Immunol, 15,
286-293.
|
 |
|
|
|
|
 |
P.A.van der Merwe,
and
S.J.Davis
(2003).
Molecular interactions mediating T cell antigen recognition.
|
| |
Annu Rev Immunol, 21,
659-684.
|
 |
|
|
|
|
 |
R.K.Strong,
M.A.Holmes,
P.Li,
L.Braun,
N.Lee,
and
D.E.Geraghty
(2003).
HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities.
|
| |
J Biol Chem, 278,
5082-5090.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.L.Hutchinson,
L.Wooldridge,
S.Tafuro,
B.Laugel,
M.Glick,
J.M.Boulter,
B.K.Jakobsen,
D.A.Price,
and
A.K.Sewell
(2003).
The CD8 T cell coreceptor exhibits disproportionate biological activity at extremely low binding affinities.
|
| |
J Biol Chem, 278,
24285-24293.
|
 |
|
|
|
|
 |
S.Radaev,
M.Kattah,
B.Rostro,
M.Colonna,
and
P.D.Sun
(2003).
Crystal structure of the human myeloid cell activating receptor TREM-1.
|
| |
Structure, 11,
1527-1535.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Y.Liu,
Y.Xiong,
O.V.Naidenko,
J.H.Liu,
R.Zhang,
A.Joachimiak,
M.Kronenberg,
H.Cheroutre,
E.L.Reinherz,
and
J.H.Wang
(2003).
The crystal structure of a TL/CD8alphaalpha complex at 2.1 A resolution: implications for modulation of T cell activation and memory.
|
| |
Immunity, 18,
205-215.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.A.Aarnoudse,
M.Krüse,
R.Konopitzky,
N.Brouwenstijn,
and
P.I.Schrier
(2002).
TCR reconstitution in Jurkat reporter cells facilitates the identification of novel tumor antigens by cDNA expression cloning.
|
| |
Int J Cancer, 99,
7.
|
 |
|
|
|
|
 |
C.Leibold,
R.Kempter,
and
J.L.van Hemmen
(2002).
How spiking neurons give rise to a temporal-feature map: from synaptic plasticity to axonal selection.
|
| |
Phys Rev E Stat Nonlin Soft Matter Phys, 65,
051915.
|
 |
|
|
|
|
 |
G.F.Gao,
Z.Rao,
and
J.I.Bell
(2002).
Molecular coordination of alphabeta T-cell receptors and coreceptors CD8 and CD4 in their recognition of peptide-MHC ligands.
|
| |
Trends Immunol, 23,
408-413.
|
 |
|
|
|
|
 |
K.Natarajan,
N.Dimasi,
J.Wang,
R.A.Mariuzza,
and
D.H.Margulies
(2002).
Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination.
|
| |
Annu Rev Immunol, 20,
853-885.
|
 |
|
|
|
|
 |
M.G.Rudolph,
and
I.A.Wilson
(2002).
The specificity of TCR/pMHC interaction.
|
| |
Curr Opin Immunol, 14,
52-65.
|
 |
|
|
|
|
 |
M.G.Rudolph,
J.G.Luz,
and
I.A.Wilson
(2002).
Structural and thermodynamic correlates of T cell signaling.
|
| |
Annu Rev Biophys Biomol Struct, 31,
121-149.
|
 |
|
|
|
|
 |
M.Glick,
D.A.Price,
A.L.Vuidepot,
T.B.Andersen,
S.L.Hutchinson,
B.Laugel,
A.K.Sewell,
J.M.Boulter,
P.R.Dunbar,
V.Cerundolo,
A.Oxenius,
J.I.Bell,
W.G.Richards,
and
B.K.Jakobsen
(2002).
Novel CD8+ T cell antagonists based on beta 2-microglobulin.
|
| |
J Biol Chem, 277,
20840-20846.
|
 |
|
|
|
|
 |
N.R.Gascoigne
(2002).
T-cell differentiation: MHC class I's sweet tooth lost on maturity.
|
| |
Curr Biol, 12,
R99.
|
 |
|
|
|
|
 |
P.E.Adrian,
G.Rajaseger,
V.S.Mathura,
M.K.Sakharkar,
and
P.Kangueane
(2002).
Types of inter-atomic interactions at the MHC-peptide interface: identifying commonality from accumulated data.
|
| |
BMC Struct Biol, 2,
2.
|
 |
|
|
|
|
 |
R.König
(2002).
Interactions between MHC molecules and co-receptors of the TCR.
|
| |
Curr Opin Immunol, 14,
75-83.
|
 |
|
|
|
|
 |
A.M.Moody,
D.Chui,
P.A.Reche,
J.J.Priatel,
J.D.Marth,
and
E.L.Reinherz
(2001).
Developmentally regulated glycosylation of the CD8alphabeta coreceptor stalk modulates ligand binding.
|
| |
Cell, 107,
501-512.
|
 |
|
|
|
|
 |
A.M.Moody,
Y.Xiong,
H.C.Chang,
and
E.L.Reinherz
(2001).
The CD8alphabeta co-receptor on double-positive thymocytes binds with differing affinities to the products of distinct class I MHC loci.
|
| |
Eur J Immunol, 31,
2791-2799.
|
 |
|
|
|
|
 |
B.E.Gewurz,
R.Gaudet,
D.Tortorella,
E.W.Wang,
H.L.Ploegh,
and
D.C.Wiley
(2001).
Antigen presentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2.
|
| |
Proc Natl Acad Sci U S A, 98,
6794-6799.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
G.Bi,
and
M.Poo
(2001).
Synaptic modification by correlated activity: Hebb's postulate revisited.
|
| |
Annu Rev Neurosci, 24,
139-166.
|
 |
|
|
|
|
 |
J.H.Wang,
R.Meijers,
Y.Xiong,
J.H.Liu,
T.Sakihama,
R.Zhang,
A.Joachimiak,
and
E.L.Reinherz
(2001).
Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule.
|
| |
Proc Natl Acad Sci U S A, 98,
10799-10804.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
N.Matsumoto,
M.Mitsuki,
K.Tajima,
W.M.Yokoyama,
and
K.Yamamoto
(2001).
The functional binding site for the C-type lectin-like natural killer cell receptor Ly49A spans three domains of its major histocompatibility complex class I ligand.
|
| |
J Exp Med, 193,
147-158.
|
 |
|
|
|
|
 |
O.de la Calle-Martin,
M.Hernandez,
J.Ordi,
N.Casamitjana,
J.I.Arostegui,
I.Caragol,
M.Ferrando,
M.Labrador,
J.L.Rodriguez-Sanchez,
and
T.Espanol
(2001).
Familial CD8 deficiency due to a mutation in the CD8 alpha gene.
|
| |
J Clin Invest, 108,
117-123.
|
 |
|
|
|
|
 |
P.M.Rudd,
T.Elliott,
P.Cresswell,
I.A.Wilson,
and
R.A.Dwek
(2001).
Glycosylation and the immune system.
|
| |
Science, 291,
2370-2376.
|
 |
|
|
|
|
 |
R.J.Bienstock,
and
J.C.Barrett
(2001).
KAI1, a prostate metastasis suppressor: prediction of solvated structure and interactions with binding partners; integrins, cadherins, and cell-surface receptor proteins.
|
| |
Mol Carcinog, 32,
139-153.
|
 |
|
|
|
|
 |
T.A.Potter,
K.Grebe,
B.Freiberg,
and
A.Kupfer
(2001).
Formation of supramolecular activation clusters on fresh ex vivo CD8+ T cells after engagement of the T cell antigen receptor and CD8 by antigen-presenting cells.
|
| |
Proc Natl Acad Sci U S A, 98,
12624-12629.
|
 |
|
|
|
|
 |
X.N.Xu,
M.A.Purbhoo,
N.Chen,
J.Mongkolsapaya,
J.H.Cox,
U.C.Meier,
S.Tafuro,
P.R.Dunbar,
A.K.Sewell,
C.S.Hourigan,
V.Appay,
V.Cerundolo,
S.R.Burrows,
A.J.McMichael,
and
G.R.Screaton
(2001).
A novel approach to antigen-specific deletion of CTL with minimal cellular activation using alpha3 domain mutants of MHC class I/peptide complex.
|
| |
Immunity, 14,
591-602.
|
 |
|
|
|
|
 |
C.Wingren,
M.P.Crowley,
M.Degano,
Y.Chien,
and
I.A.Wilson
(2000).
Crystal structure of a gammadelta T cell receptor ligand T22: a truncated MHC-like fold.
|
| |
Science, 287,
310-314.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.J.Sundberg,
and
R.A.Mariuzza
(2000).
Luxury accommodations: the expanding role of structural plasticity in protein-protein interactions.
|
| |
Structure, 8,
R137-R142.
|
 |
|
|
|
|
 |
G.F.Gao,
B.E.Willcox,
J.R.Wyer,
J.M.Boulter,
C.A.O'Callaghan,
K.Maenaka,
D.I.Stuart,
E.Y.Jones,
P.A.Van Der Merwe,
J.I.Bell,
and
B.K.Jakobsen
(2000).
Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8alphaalpha.
|
| |
J Biol Chem, 275,
15232-15238.
|
 |
|
|
|
|
 |
J.Wang,
and
E.L.Reinherz
(2000).
Structural basis of cell-cell interactions in the immune system.
|
| |
Curr Opin Struct Biol, 10,
656-661.
|
 |
|
|
|
|
 |
O.Schueler-Furman,
Y.Altuvia,
A.Sette,
and
H.Margalit
(2000).
Structure-based prediction of binding peptides to MHC class I molecules: application to a broad range of MHC alleles.
|
| |
Protein Sci, 9,
1838-1846.
|
 |
|
|
|
|
 |
Z.Huang
(2000).
Structural chemistry and therapeutic intervention of protein-protein interactions in immune response, human immunodeficiency virus entry, and apoptosis.
|
| |
Pharmacol Ther, 86,
201-215.
|
 |
|
|
|
|
 |
D.Dietrich,
T.Kral,
H.Clusmann,
M.Friedl,
and
J.Schramm
(1999).
Reduced function of L-AP4-sensitive metabotropic glutamate receptors in human epileptic sclerotic hippocampus.
|
| |
Eur J Neurosci, 11,
1109-1113.
|
 |
|
|
|
|
 |
H.Firat,
F.Garcia-Pons,
S.Tourdot,
S.Pascolo,
A.Scardino,
Z.Garcia,
M.L.Michel,
R.W.Jack,
G.Jung,
K.Kosmatopoulos,
L.Mateo,
A.Suhrbier,
F.A.Lemonnier,
and
P.Langlade-Demoyen
(1999).
H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies.
|
| |
Eur J Immunol, 29,
3112-3121.
|
 |
|
|
|
|
 |
K.C.Garcia,
L.Teyton,
and
I.A.Wilson
(1999).
Structural basis of T cell recognition.
|
| |
Annu Rev Immunol, 17,
369-397.
|
 |
|
|
|
|
 |
K.C.Garcia
(1999).
Molecular interactions between extracellular components of the T-cell receptor signaling complex.
|
| |
Immunol Rev, 172,
73-85.
|
 |
|
|
|
|
 |
K.Hashimoto,
K.Okamura,
H.Yamaguchi,
M.Ototake,
T.Nakanishi,
and
Y.Kurosawa
(1999).
Conservation and diversification of MHC class I and its related molecules in vertebrates.
|
| |
Immunol Rev, 167,
81.
|
 |
|
|
|
|
 |
K.Maenaka,
and
E.Y.Jones
(1999).
MHC superfamily structure and the immune system.
|
| |
Curr Opin Struct Biol, 9,
745-753.
|
 |
|
|
|
|
 |
L.Devine,
and
P.B.Kavathas
(1999).
Molecular analysis of protein interactions mediating the function of the cell surface protein CD8.
|
| |
Immunol Res, 19,
201-210.
|
 |
|
|
|
|
 |
L.M.Sánchez,
A.J.Chirino,
and
P.Bjorkman
(1999).
Crystal structure of human ZAG, a fat-depleting factor related to MHC molecules.
|
| |
Science, 283,
1914-1919.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Q.R.Fan,
and
D.C.Wiley
(1999).
Structure of human histocompatibility leukocyte antigen (HLA)-Cw4, a ligand for the KIR2D natural killer cell inhibitory receptor.
|
| |
J Exp Med, 190,
113-123.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Q.Zen,
M.Cottman,
G.Truskey,
R.Fraser,
and
M.J.Telen
(1999).
Critical factors in basal cell adhesion molecule/lutheran-mediated adhesion to laminin.
|
| |
J Biol Chem, 274,
728-734.
|
 |
|
|
|
|
 |
T.R.Petersen,
S.Bregenholta,
L.O.Pedersen,
M.H.Nissen,
and
M.H.Claesson
(1999).
Human p53(264-272) HLA-A2 binding peptide is an immunodominant epitope in DNA-immunized HLA-A2 transgenic mice.
|
| |
Cancer Lett, 137,
183-191.
|
 |
|
|
|
|
 |
W.Ellmeier,
S.Sawada,
and
D.R.Littman
(1999).
The regulation of CD4 and CD8 coreceptor gene expression during T cell development.
|
| |
Annu Rev Immunol, 17,
523-554.
|
 |
|
|
|
|
 |
B.Arden
(1998).
Conserved motifs in T-cell receptor CDR1 and CDR2: implications for ligand and CD8 co-receptor binding.
|
| |
Curr Opin Immunol, 10,
74-81.
|
 |
|
|
|
|
 |
B.C.Sim,
D.Lo,
and
N.R.Gascoigne
(1998).
Preferential expression of TCR V alpha regions in CD4/CD8 subsets: class discrimination or co-receptor recognition?
|
| |
Immunol Today, 19,
276-282.
|
 |
|
|
|
|
 |
C.A.O'Callaghan,
and
J.I.Bell
(1998).
Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G.
|
| |
Immunol Rev, 163,
129-138.
|
 |
|
|
|
|
 |
E.J.Collins,
and
J.A.Frelinger
(1998).
Altered peptide ligand design: altering immune responses to class I MHC/peptide complexes.
|
| |
Immunol Rev, 163,
151-160.
|
 |
|
|
|
|
 |
E.Y.Jones,
J.Tormo,
S.W.Reid,
and
D.I.Stuart
(1998).
Recognition surfaces of MHC class I.
|
| |
Immunol Rev, 163,
121-128.
|
 |
|
|
|
|
 |
G.E.Kwan Lim,
L.McNeill,
K.Whitley,
D.L.Becker,
and
R.Zamoyska
(1998).
Co-capping studies reveal CD8/TCR interactions after capping CD8 beta polypeptides and intracellular associations of CD8 with p56(lck).
|
| |
Eur J Immunol, 28,
745-754.
|
 |
|
|
|
|
 |
G.F.Gao,
U.C.Gerth,
J.R.Wyer,
B.E.Willcox,
C.A.O'Callaghan,
Z.Zhang,
E.Y.Jones,
J.I.Bell,
and
B.K.Jakobsen
(1998).
Assembly and crystallization of the complex between the human T cell coreceptor CD8alpha homodimer and HLA-A2.
|
| |
Protein Sci, 7,
1245-1249.
|
 |
|
|
|
|
 |
G.Mazza,
D.Housset,
C.Piras,
C.Gregoire,
S.Y.Lin,
J.C.Fontecilla-Camps,
and
B.Malissen
(1998).
Glimpses at the recognition of peptide/MHC complexes by T-cell antigen receptors.
|
| |
Immunol Rev, 163,
187-196.
|
 |
|
|
|
|
 |
I.A.Wilson,
and
P.J.Bjorkman
(1998).
Unusual MHC-like molecules: CD1, Fc receptor, the hemochromatosis gene product, and viral homologs.
|
| |
Curr Opin Immunol, 10,
67-73.
|
 |
|
|
|
|
 |
I.D.Campbell
(1998).
The modular architecture of leukocyte cell-surface receptors.
|
| |
Immunol Rev, 163,
11-18.
|
 |
|
|
|
|
 |
J.Gong,
S.Stenger,
J.A.Zack,
B.E.Jones,
G.C.Bristol,
R.L.Modlin,
P.J.Morrissey,
and
P.F.Barnes
(1998).
Isolation of mycobacterium-reactive CD1-restricted T cells from patients with human immunodeficiency virus infection.
|
| |
J Clin Invest, 101,
383-389.
|
 |
|
|
|
|
 |
K.C.Garcia,
M.Degano,
L.R.Pease,
M.Huang,
P.A.Peterson,
L.Teyton,
and
I.A.Wilson
(1998).
Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen.
|
| |
Science, 279,
1166-1172.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.M.Davis,
J.J.Boniface,
Z.Reich,
D.Lyons,
J.Hampl,
B.Arden,
and
Y.Chien
(1998).
Ligand recognition by alpha beta T cell receptors.
|
| |
Annu Rev Immunol, 16,
523-544.
|
 |
|
|
|
|
 |
P.S.Kern,
M.K.Teng,
A.Smolyar,
J.H.Liu,
J.Liu,
R.E.Hussey,
R.Spoerl,
H.C.Chang,
E.L.Reinherz,
and
J.H.Wang
(1998).
Structural basis of CD8 coreceptor function revealed by crystallographic analysis of a murine CD8alphaalpha ectodomain fragment in complex with H-2Kb.
|
| |
Immunity, 9,
519-530.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.Zamoyska
(1998).
CD4 and CD8: modulators of T-cell receptor recognition of antigen and of immune responses?
|
| |
Curr Opin Immunol, 10,
82-87.
|
 |
|
|
|
|
 |
S.Choksi,
B.A.Jameson,
and
R.Korngold
(1998).
A structure-based approach to designing synthetic CD8alpha peptides that can inhibit cytotoxic T-lymphocyte responses.
|
| |
Nat Med, 4,
309-314.
|
 |
|
|
|
|
 |
S.J.Davis,
E.A.Davies,
M.G.Tucknott,
E.Y.Jones,
and
P.A.van der Merwe
(1998).
The role of charged residues mediating low affinity protein-protein recognition at the cell surface by CD2.
|
| |
Proc Natl Acad Sci U S A, 95,
5490-5494.
|
 |
|
|
|
|
 |
S.Li,
S.Choksi,
S.Shan,
X.Hu,
J.Gao,
R.Korngold,
and
Z.Huang
(1998).
Identification of the CD8 DE loop as a surface functional epitope. Implications for major histocompatibility complex class I binding and CD8 inhibitor design.
|
| |
J Biol Chem, 273,
16442-16445.
|
 |
|
|
|
|
 |
V.M.Braud,
D.S.Allan,
D.Wilson,
and
A.J.McMichael
(1998).
TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide.
|
| |
Curr Biol, 8,
1.
|
 |
|
|
|
|
 |
Z.Weng,
and
C.DeLisi
(1998).
Toward a predictive understanding of molecular recognition.
|
| |
Immunol Rev, 163,
251-266.
|
 |
|
|
|
|
 |
F.C.Arnett,
and
R.Chakraborty
(1997).
Ankylosing spondylitis: the dissection of a complex genetic disease.
|
| |
Arthritis Rheum, 40,
1746-1748.
|
 |
|
|
|
|
 |
V.L.Murthy,
and
L.J.Stern
(1997).
The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding.
|
| |
Structure, 5,
1385-1396.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
| |